Moderna ($MRNA) stock surged 130% following reports that a cancer vaccine showed signs of preventing melanoma from spreading.



Moderna, mRNA (haberci RNA) tedavileri ve aşıları üzerine odaklanmış, genel merkezi Cambridge, Massachusetts'te bulunan Amerikalı bir biyoteknoloji şirketidir.
Moderna ($MRNA) stock surged 130% following reports that a cancer vaccine showed signs of preventing melanoma from spreading.
Moderna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.